Evidence supports that ICAM1 binds to MUC1, which is known to be overexpressed in cancer cells and cancer stem cells, and CD80 binds to CTLA4, which is an immunosuppressive marker that is also expressed in cancer stem cells. This evidence concerns the gene ICAM1 and cancer.